Bi-Dar Wang

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 17

Top Topics

African American

Myasthenia Gravis

Cell Proliferation

Top Venues

International journal of molecular sciences

Molecular cancer research : MCR

This page only lists publications with an associated author ORCID identifier.

Publications

Mohammad Waseem, Bi-Dar Wang
Organoids: An Emerging Precision Medicine Model for Prostate Cancer Research. International journal of molecular sciences 25 (2) (2024)
Mohammad Waseem, Bi-Dar Wang
Organoids: An Emerging Precision Medicine Model for Prostate Cancer Research. International journal of molecular sciences 25 (2) (2024)
Mohammad Waseem, Bi-Dar Wang
Organoids: An Emerging Precision Medicine Model for Prostate Cancer Research. International journal of molecular sciences 25 (2) (2024)
Mohammad Waseem, Bi-Dar Wang
Combination of miR-99b-5p and Enzalutamide or Abiraterone Synergizes the Suppression of EMT-Mediated Metastasis in Prostate Cancer. Cancers 16 (10) (2024)
Mohammad Waseem, Bi-Dar Wang
Combination of miR-99b-5p and Enzalutamide or Abiraterone Synergizes the Suppression of EMT-Mediated Metastasis in Prostate Cancer. Cancers 16 (10) (2024)
Mohammad Waseem, Bi-Dar Wang
Promising Strategy of mPTP Modulation in Cancer Therapy: An Emerging Progress and Future Insight. International journal of molecular sciences 24 (6) (2023)
Siyoung Ha, Bi-Dar Wang
Molecular Insight into Drug Resistance Mechanism Conferred by Aberrant PIK3CD Splice Variant in African American Prostate Cancer. Cancers 15 (4) (2023)
Himali Gujrati, Siyoung Ha, Bi-Dar Wang
Deregulated microRNAs Involved in Prostate Cancer Aggressiveness and Treatment Resistance Mechanisms. Cancers 15 (12) (2023)
Siyoung Ha, Bi-Dar Wang
Molecular Insight into Drug Resistance Mechanism Conferred by Aberrant PIK3CD Splice Variant in African American Prostate Cancer. Cancers 15 (4) (2023)
Mohammad Waseem, Bi-Dar Wang
Promising Strategy of mPTP Modulation in Cancer Therapy: An Emerging Progress and Future Insight. International journal of molecular sciences 24 (6) (2023)
Siyoung Ha, Bi-Dar Wang
Molecular Insight into Drug Resistance Mechanism Conferred by Aberrant PIK3CD Splice Variant in African American Prostate Cancer. Cancers 15 (4) (2023)
Himali Gujrati, Siyoung Ha, Bi-Dar Wang
Deregulated microRNAs Involved in Prostate Cancer Aggressiveness and Treatment Resistance Mechanisms. Cancers 15 (12) (2023)
Mohammad Waseem, Bi-Dar Wang
Promising Strategy of mPTP Modulation in Cancer Therapy: An Emerging Progress and Future Insight. International journal of molecular sciences 24 (6) (2023)
Himali Gujrati, Siyoung Ha, Azah Mohamed, Bi-Dar Wang
MicroRNA-mRNA Regulatory Network Mediates Activation of mTOR and VEGF Signaling in African American Prostate Cancer. International journal of molecular sciences 23 (6) (2022)
Himali Gujrati, Siyoung Ha, Mohammad Waseem, Bi-Dar Wang
Downregulation of miR-99b-5p and Upregulation of Nuclear mTOR Cooperatively Promotes the Tumor Aggressiveness and Drug Resistance in African American Prostate Cancer. International journal of molecular sciences 23 (17) (2022)
Jacqueline Olender, Bi-Dar Wang, Travers Ching, Liangqun Lu, Kaitlin Garofano, Youngmi Ji, Tessa Knox, Patricia S Latham, Kenneth Nguyen, Johng Rhim, Norman H Lee
A Novel FGFR3 Splice Variant Preferentially Expressed in African American Prostate Cancer Drives Aggressive Phenotypes and Docetaxel Resistance. Molecular cancer research : MCR 17 (10) (2019)
Manjistha Sengupta, Bi-Dar Wang, Norman H Lee, Alexander Marx, Linda L Kusner, Henry J Kaminski
MicroRNA and mRNA expression associated with ectopic germinal centers in thymus of myasthenia gravis. PloS one 13 (10) (2018)